Differentiating biologics to prevent psoriatic arthritis in patients with psoriasis - Authors' reply
Lancet Rheumatol
.
2023 Jun;5(6):e313.
doi: 10.1016/S2665-9913(23)00124-8.
Authors
Shikha Singla
1
,
Michael Putman
2
,
Jean Liew
3
,
Kenneth Gordon
4
Affiliations
1
Department of Rheumatology, Medical College of Wisconsin, Milwaukee, WI 53226, USA. Electronic address: ssingla@mcw.edu.
2
Department of Rheumatology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
3
Department of Rheumatology, Boston University Chobanian and Avedisian School of Medicine, Boston University, Boston, MA, USA.
4
Department of Dermatology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
PMID:
38251598
DOI:
10.1016/S2665-9913(23)00124-8
No abstract available
Publication types
Letter
MeSH terms
Arthritis, Psoriatic* / complications
Biological Products* / therapeutic use
Humans
Patients
Psoriasis* / complications
Substances
Biological Products